Second version of Brief Evaluation of Psychosis Symptom Domains (BE-PSD-V2.0).

Competing Interests: Declaration of competing interest Dr. Takeuchi has grants from Daiichi Sankyo and Novartis Pharma; speaker's fees from EA Pharma, Kyowa, Janssen, Lundbeck, Meiji Seika Pharma, Mochida, Otsuka, Sumitomo Pharma, Takeda, and Yoshitomiyakuhin; and consultant fees from Janssen, Mitsubishi Tanabe Pharma, and Sumitomo Pharma. Mr. Fervaha has no competing interests to disclose. Dr. Lee has received speaker's fees from Janssen, Lundbeck, Otsuka, and Sumitomo Pharma; and consultant fees from Otsuka. Dr. Agid has received grants from Boehringer Ingelheim, diaMentis, Janssen, Lundbeck, Neurocrine Biosciences, and Otsuka; speaker's fees from Janssen, HLS Therapeutics, Lundbeck, Medscape, Viatris, and Otsuka; and consultant fees from AbbVie, Janssen, Lundbeck, Minerva Neuroscience, Viatris, and Otsuka. Dr. Remington has received grants from the Canadian Institutes of Health Research (CIHR), University of Toronto, and HLS Therapeutics.